Global Breast Biopsy Market: By Product (Biopsy Needles, Biopsy Tables), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy), Guidance Technology (Ultrasound-Guided, CT-Guided Biopsy), End-Users (Hospitals, Labs) –Global Forecast Till 2023Increased cancer detection rates globally have contributed to a rise in biopsy procedures.

The report covers the COVID-19 analysis of the global breast biopsy market and provides a detailed summary of market segments, current trends, growth projections, and market challenges from 2018 to 2023 (forecast period) to identify potential business opportunities.Free Sample Copy of  With Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6288  A biopsy is a small operation performed to remove tissue from the area of concern within the body.

There are various types of biopsy procedures depending on the technique, such as fine needle aspiration biopsy (FNAB), core needle biopsy (CNB), and vacuum-assisted biopsy (VAB) prescribed by the doctor based on the size, location, and other characteristics of the breast abnormality.

In addition, market limitations include the high cost of surgical procedures and the complications involved.

Conversely, the advent of technologically advanced and minimally invasive breast biopsy devices is expected to create lucrative opportunities in the untapped market.

Surgical biopsy is divided into incisional biopsy and excisional biopsy.Based on guidance technology, the global market for breast biopsy has been classified into CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and other image-guided breast biopsy (PET and thermography).Based on end-user, the global market for breast biopsy has been divided into hospitals, ambulatory surgical centers, diagnostic centers, and others.

We specialize in performing breast surgery, breast biopsy and breast augmentation procedures in Texas.

This form of biopsy is conducted with the help of minimally invasive biopsy systems due to minimal pain and disfigurement.

The global breast biopsy market is expected to expand in significant fashion during the forecast period of 2018 to 2023.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/6288The increasing prevalence of breast cancer, especially for women above 35 years of age during menopause, who are more susceptible to breast cancer, and rising awareness concerning breast cancer screening programs are the major drivers of the market.

In addition to these, the market growth is also restricted due to the high cost of surgical procedures and the risks associated with them.

At the same time, the emergence of technologically advanced and the usage of breast biopsy devices that are minimally invasive are expected to tap into the potential opportunities that the market holds.Market SegmentationThe global breast biopsy market segmentation is done as per technique type, product, guidance technology, and end-user.By product, the market includes biopsy tables, guidance systems, biopsy needles, biopsy wires, and others.By technique type, the market includes core needle biopsy, fine needle aspiration biopsy, wire localization, MRI-guided core needle biopsy, biopsy markers, surgical biopsy, and sentinel node biopsy.

The surgical biopsy segment is divided into excisional biopsy and incisional biopsy.By guidance technology, the market includes CT-guided biopsy, ultrasound-guided, mammography-guided magnetic resonance, and various other image-guided breast biopsy (PET and thermography).By end-user, the market comprises of ambulatory surgical centers, hospitals, diagnostic centers, and others.Regional AnalysisThe geographical breast biopsy market segmentation covers four major regions, namely North America, Asia-Pacific, Europe, and the Middle East & Africa.North America is anticipated to hold the largest market share over the forecast period as per the market report published by MRFR.

The Europe market holds the second-largest share of the breast biopsy market due to the striking prevalence of breast cancer in the UK and Belgium.

Global breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, P Market ResearchOn the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy.

Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now.

It is also expected to be the fastest growing category during the forecast period.

This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sampleOn the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products.

Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share.

For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago.

According to a new market research report Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022, published by MarketsandMarkets™, the market is expected to reach USD 2.42 Billion by 2022 from an estimated USD 1.74 Billion in 2017, at a CAGR of 6.8% during the forecast period.Browse 180 Market Data Tables and 42 Figures spread through 219 Pages and in-depth TOC on "Biopsy Devices Market"Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=132886515 The Report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.Factors such as rising prevalence of cancer, increasing preference for minimally invasive surgeries, and initiatives undertaken by governments & global health organizations are the major factors driving the growth of this market.By product, the needle-based biopsy instruments segment accounted for the largest share of the marketOn the basis of product, the needle-based biopsy instruments segment accounted for the largest share of the global biopsy devices market in 2016.

This can be attributed to the preference of needle-based biopsies over open surgical biopsies and increasing preference for minimally invasive surgeries.The lung biopsy segment is expected to highest growth during the forecast periodBased on application, the lung biopsy segment accounted for the largest share of the biopsy devices market.

Additionally, the availability of funding for lung cancer research is contributing to the growth of this market segment.The ultrasound-guided biopsy segment dominated the market in 2016Based on guidance technique, the ultrasound-guided biopsy segment accounted for the largest share of the biopsy devices market.

This quick and simple procedure offers advantages, such as no ionizing radiation exposure, low complication rate, and lower cost as compared to other biopsy techniques.The hospitals segment held the highest CAGR during the forecast periodBased on end user, the hospitals segment is expected to register the highest growth rate during the forecast period.

The strong financial capabilities of hospitals and the presence of trained professionals are the major factors supporting the rising adoption of biopsy devices among hospitals.North America dominated the market in 2016North America accounted for the largest share of the biopsy devices market in 2016, followed by Europe.

The rising prevalence of cancer, government initiatives to spread awareness about cancer, favorable reimbursement scenario for biopsy devices in the U.S., and the presence of key players in the region are the key factors driving the growth of the biopsy devices market in North America.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515 The major players in the biopsy devices market are C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.